Thyrocare Technologies share news, announcements and annual reports
NSE: THYROCAREBSE: 539871Healthcare ServicesSmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹515.50.
30 Oct: open ₹496.05, high ₹503.50, low ₹445.30
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7,263 Cr673rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 50.36
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹51 crore of one-off items, the largest of them in the quarter to Sep 2026.
- 37.18
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 13.12
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.53%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 26.5%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹51 crore of one-off items, the largest of them in the quarter to Sep 2026.
- 35.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 43.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 60,51,03840.9% delivered
Thyrocare Technologies share news and announcements
650 announcements, routine notices left out, newest first. Page 9 of 13.
Dec 2019
2 Dec · Analysts
Nov 2019
28 Nov · Analysts
23 Nov · Analysts
20 Nov · Analysts
8 Nov · Corporate action
7 Nov · Results
Oct 2019
3 Oct · Analysts
Sep 2019
26 Sep · Analysts
21 Sep · Board meeting
19 Sep · Board meeting
18 Sep · Analysts
11 Sep · Analysts
Aug 2019
26 Aug · Analysts
24 Aug · Meeting
17 Aug · Analysts
13 Aug · Results
12 Aug · Analysts
10 Aug · Results
10 Aug · Board meeting
Jul 2019
31 Jul · Meeting
4 Jul · Analysts
1 Jul · Analysts
Jun 2019
29 Jun · Analysts
24 Jun · Analysts
17 Jun · Related Party Transactions
13 Jun · Board meeting
12 Jun · Analysts
10 Jun · Board meeting
May 2019
27 May · Analysts
23 May · Analysts
21 May · Analysts
20 May · Corrigendum
20 May · Analysts
18 May · Results
Apr 2019
30 Apr · Analysts
10 Apr · Analysts